| View |
|
DRP-9991-01
|
Oxytocin
|
Ergitocin
|
10 IU/mL
|
Solution for Injection (IM/IV)
|
-
|
Harmann Pharmaceutical Laboratories (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
17 January 2023
|
21 April 2025
|
| View |
|
DRP-10199-08
|
Trimetazidine Hydrochloride
|
Mertazine
|
35mg
|
Modified Release Tablet
|
-
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
17 January 2023
|
04 August 2026
|
| View |
|
DRP-10892-02
|
Zoledronic Acid (as monohydrate)
|
Golendronic
|
800 mcg/mL (4 mg/5 mL)
|
Concentrated Solution for Injection (IV Infusion)
|
-
|
Aroma ?laç San. Ltd. ?ti
|
Turkey
|
CLIDP Conversion
|
17 January 2023
|
14 December 2026
|
| View |
|
DRP-11027-02
|
Progesterone
|
Progestedin
|
200 mg
|
Soft Gelatin Oral Capsule
|
-
|
Akums Drugs & Pharmaceuticals Ltd. (Plant IV - Hormonals)
|
India
|
CLIDP Conversion
|
17 January 2023
|
06 January 2027
|
| View |
|
DRP-11402-03
|
Folic Acid
|
Folimer
|
5mg
|
Film-Coated Tablet
|
-
|
Acme Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
17 January 2023
|
09 March 2027
|
| View |
|
DRP-11837-03
|
Losartan Potassium + Amlodipine (as besilate)
|
Losam
|
50 mg/5 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
17 January 2023
|
10 February 2025
|
| View |
|
DRP-5769-07
|
Gliclazide
|
Gluconex MR
|
30 mg
|
Modified-Release Tablet
|
Oral Hypoglycemic Agent
|
Bal Pharma Ltd
|
India
|
Renewal
|
15 May 2024
|
13 June 2029
|
| View |
|
DRP-7491-01
|
Amlodipine (as besilate)
|
Amvic
|
10 mg
|
Tablet
|
-
|
J. Duncan Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
14 January 2023
|
22 November 2026
|
| View |
|
DRP-12561-02
|
Metformin hydrochloride
|
Rafor
|
500 mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
14 January 2023
|
02 September 2027
|
| View |
|
BRP-065-04
|
Insulin Human (rDNA)
|
Insunova-N
|
100 IU/mL
|
Suspension for Injection (IM/SC) (100% Isophane Insulin Human)
|
-
|
M.J. Biopharm Pvt., Ltd
|
India
|
CLIDP Conversion
|
11 January 2023
|
28 August 2026
|
| View |
|
DRP-5240-22
|
Ceftriaxone (as sodium)
|
Rexone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Scott-Edil Advance Research Laboratories & Education Limited
|
India
|
Renewal
|
07 May 2024
|
07 April 2029
|
| View |
|
DRP-12411-01
|
Sevelamer carbonate
|
Sevlafixx
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 January 2023
|
03 August 2027
|
| View |
|
DRP-11044-02
|
Potassium Citrate
|
Rexcitrate
|
1080 mg
|
Extended-Release Tablet
|
-
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
09 January 2023
|
18 January 2027
|
| View |
|
DRP-11462-04
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazohil 400
|
4 g /500 mg
|
Powder for Injection (I.V.)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
09 January 2023
|
15 March 2027
|
| View |
|
DRP-11898-01
|
Ceftriaxone (as Sodium)
|
Triaxcef
|
1g
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
09 January 2023
|
18 May 2027
|
| View |
|
DRP-12412-06
|
Losartan Potassium
|
Kozartan
|
50 mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
09 January 2023
|
03 August 2025
|
| View |
|
DRP-13059-01
|
Telmisartan + Amlodipine (as besilate)
|
Mistacor AM
|
40 mg/ 5 mg
|
Tablet
|
-
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
09 January 2023
|
24 November 2027
|
| View |
|
DRP-13089-01
|
Telmisartan + Amlodipine (as besilate)
|
Mistacor AM
|
80 mg/ 10 mg
|
Tablet
|
-
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
09 January 2023
|
28 November 2027
|
| View |
|
DRP-3704-06
|
Co-Amoxiclav
|
Wesclav
|
250 mg/ 62.5 mg per 5 mL
|
Powder for Suspension
|
Antibacterials (Penicillins)
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
09 January 2023
|
21 October 2026
|
| View |
|
DRP-5052-24
|
Cefixime (as trihydrate)
|
Kenzocef
|
100 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Third Generation Cephalosporins)
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
09 January 2023
|
18 August 2027
|